BioElectronics enters Mexican market:
This article was originally published in Clinica
BioElectronics (Frederick, Maryland) has announced a distribution agreement with Mexican firm Eximeq to introduce its ActiPatch technology to the latter's domestic market. ActiPatch is a drug-free, anti-inflammatory device with embedded microchip technology that administers weeks of continuous pulsed tissue therapy to treat swelling, pain and soft and hard tissue injuries for less than a dollar a day. BioElectronics claims that ActiPatch has been clinically proven to reduce swelling and bruising by 50%.